KBI Biopharma SA and Selexis SA, both JSR Life Sciences companies, has opened an fully-integrated mammalian contract development and manufacturing services facility in Geneva, Switzerland.   The ~94,000 square-foot KBI/Selexis state-of-the-art facility builds on the companies’ existing expertise combining cell line development (CLD) and mammalian cell manufacturing in a single location.     This expansion enables delivery of client programs through increased quality, efficiency, and time sav...